FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

Current stock price

38.71 EUR
-0.04 (-0.1%)
Last:

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FME was profitable.
  • FME had a positive operating cash flow in the past year.
  • FME had positive earnings in each of the past 5 years.
  • In the past 5 years FME always reported a positive cash flow from operatings.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.16%, FME is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
  • FME has a Return On Equity (7.35%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 5.30%, FME is in line with its industry, outperforming 59.26% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for FME is in line with the industry average of 5.73%.
  • The last Return On Invested Capital (5.30%) for FME is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of FME (4.98%) is better than 77.78% of its industry peers.
  • FME's Profit Margin has declined in the last couple of years.
  • FME has a Operating Margin of 9.00%. This is in the better half of the industry: FME outperforms 70.37% of its industry peers.
  • In the last couple of years the Operating Margin of FME has declined.
  • FME has a Gross Margin (25.62%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of FME has declined.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • FME has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for FME has been reduced compared to 1 year ago.
  • Compared to 5 years ago, FME has less shares outstanding
  • The debt/assets ratio for FME is higher compared to a year ago.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FME has a better Altman-Z score (1.82) than 62.96% of its industry peers.
  • The Debt to FCF ratio of FME is 6.19, which is on the high side as it means it would take FME, 6.19 years of fcf income to pay off all of its debts.
  • FME has a better Debt to FCF ratio (6.19) than 74.07% of its industry peers.
  • FME has a Debt/Equity ratio of 0.65. This is a neutral value indicating FME is somewhat dependend on debt financing.
  • FME has a better Debt to Equity ratio (0.65) than 81.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.82
ROIC/WACC1.05
WACC5.06%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that FME should not have too much problems paying its short term obligations.
  • FME has a Current ratio of 1.26. This is in the better half of the industry: FME outperforms 62.96% of its industry peers.
  • A Quick Ratio of 0.92 indicates that FME may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.92, FME is in line with its industry, outperforming 59.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. FME.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.51% yearly.
  • The Revenue has been growing slightly by 1.51% in the past year.
  • Measured over the past years, FME shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.50% on average over the next years. This is quite good.
  • FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y8.5%
Revenue Next Year-0.88%
Revenue Next 2Y1.45%
Revenue Next 3Y2.08%
Revenue Next 5Y3.16%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.02, the valuation of FME can be described as reasonable.
  • Based on the Price/Earnings ratio, FME is valued cheaper than 88.89% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, FME is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.40, the valuation of FME can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, FME is valued cheaper than 96.30% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.99, FME is valued rather cheaply.
Industry RankSector Rank
PE 9.02
Fwd PE 9.4
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • FME's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FME is cheaper than 81.48% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, FME is valued cheaper than 81.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.51
EV/EBITDA 6.02
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y5.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. FME.DE Dividend Analysis

5.1 Amount

  • FME has a Yearly Dividend Yield of 3.82%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.64, FME pays a better dividend. On top of this FME pays more dividend than 96.30% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

  • The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years3
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.19%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (4/28/2026, 7:00:00 PM)

38.71

-0.04 (-0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.36B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.41 (17.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.82%
PT rev (3m)-4.5%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)29.21%
EPS NY rev (1m)2.65%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-1.61%
Revenue NY rev (3m)-3.66%
Valuation
Industry RankSector Rank
PE 9.02
Fwd PE 9.4
P/S 0.58
P/FCF 6.51
P/OCF 4.24
P/B 0.85
P/tB N/A
EV/EBITDA 6.02
EPS(TTM)4.29
EY11.08%
EPS(NY)4.12
Fwd EY10.63%
FCF(TTM)5.94
FCFY15.35%
OCF(TTM)9.14
OCFY23.6%
SpS66.89
BVpS45.36
TBVpS-5.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number66.1712 (70.94%)
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.82
F-Score8
WACC5.06%
ROIC/WACC1.05
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y8.5%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.88%
Revenue Next 2Y1.45%
Revenue Next 3Y2.08%
Revenue Next 5Y3.16%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year70.62%
EBIT Next 3Y23.59%
EBIT Next 5Y14.58%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.


How profitable is FRESENIUS MEDICAL CARE AG (FME.DE) stock?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FME stock?

The financial health rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 5 / 10.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.